Navigation Links
China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
Date:1/29/2008

Accounts receivable (net

of allowance for doubtful

accounts of $39,427 in

2007, $59,098 in 2006) 749,103 706,858

Inventories 103,176 174,502

Deposits paid 331,257 548,238

Deferred tax assets 132,296 387,801

Other receivables 1,077,967 114,214

Total Current Assets $7,187,301 $4,520,699

Property and equipment, net 1,964,787 1,949,426

Intangible assets, net 9,031,420 8,807,952

Deferred taxes 115,109 329,001

TOTAL ASSETS $18,298,617 $15,607,078

LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities

Accounts payable $82,367.00 $78,070.00

Receipt in advance 65,978.00 21,176.00

Amounts due to related parties 385,838.00 172,404.00

Other payables and accrued

liabilities 1,937,791.00 1,449,576.00

Secured short-term bank loan 1,315,000.00 641,231.00

TOTAL CURRENT LIABILITIES 3,786,974.00 2,362,457.00

Long-term other loans 197,250.00 192,369.00

TOTAL LIABILITIES COMMITMENTS AND

CONTINGENCIES 3,984,224.00 2,554,826.00

STOCKHOLDERS' EQUITY

Registered and paid up common stock 7,852,802 7,852,802

Additional paid-in capital 5,941,551 5,941,551

Accumulated deficits -559,779 -1,476,381

Accumulated other comprehensive income 1,079,819 734,
'/>"/>

SOURCE Xi'an Landway Bionanometer Technology Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000
2. PPD Expands Global Central Lab Services into China
3. WuXi PharmaTech (NYSE: WX) CEO Honored among the 2007 China Top 10 Influential Entrepreneurs
4. China Biologic Products Gains Financial Support from Shandong Provincial Government on the Improvement of Production Facilities
5. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
6. Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility
7. China Medical Technologies Completes Acquisition of BBE
8. Three Steps to Boost Asymchems Investment in China
9. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results
10. AMDLs First Full Service JPGreen Health and Personal Care Center Set to Open in Hangzhou, China
11. CYIG Awarded Chinas "Top 100 Enterprises" in New Pharmaceuticals, Selected as National "Torch Plan Key High-Tech Enterprise"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 2013 New interactive learning ... thought leaders of the medical device industry at ... and expo, from June 18-20 in ... http://photos.prnewswire.com/prnh/20130517/613829 ) , These all-new ... professionals practical presentations and implementable solutions on the ...
(Date:5/17/2013)... , May 17, 2013  Yongye International, Inc. (NASDAQ: ... leading developer, manufacturer, and distributor of crop nutrient products ... , today announced that, on May 16, 2013, the ... directors (the "Board of Directors") was provided a letter ... Hong Kong ) Limited ("Abax") to Full Alliance ...
(Date:5/17/2013)... -- Insero Health, Inc., a company developing natural compounds to ... disorders, is today reporting top-line results from a Phase ... with drug-resistant epilepsy.  The data are being presented at ... by Dr. Steven Schachter , Harvard ... Board.  In this study, INS001 appeared safe and well ...
(Date:5/17/2013)... Canada (PRWEB) May 17, 2013 The ... understanding complex biological systems that can help predict the ... speaker Dr. Sergey Stepaniants, Head of Computational Biology at ... computational biology tools to ensure high-quality genomics when used ... can be applied to complex data sets to identify ...
Breaking Biology Technology:MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2
... TORONTO, Sept. 19, 2011 Generex Biotechnology Corporation,s ... Express, Inc. ( www.antigenexpress.com ), today announced that ... of breast, prostate, and other cancers, is reviewed ... Opinion on Biological Therapy , a peer-reviewed, international ...
... 19, 2011 BioRestorative Therapies, Inc. (OTCQB: BRTX) (the "Company"), ... its common stock is now trading on the OTCQB market ... trading symbol for its common stock has been changed from ... and Chief Executive Officer, said, "The commencement of trading using ...
... Calif., Sept. 19, 2011 OptiScan Biomedical Corporation, ... for use in intensive care units (ICU), today ... Monitoring System has received CE Mark certification for ... certifies that the OptiScanner has met all relevant ...
Cached Biology Technology:Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy 2Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy 3Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy 4Antigen Express Cancer Vaccine Highlighted in Expert Opinion on Biological Therapy 5BioRestorative Therapies, Inc. Begins Trading Under New Name and Symbol ("BRTX") 2OptiScan Biomedical Receives CE Mark for OptiScanner Automatic Bedside Glucose Monitoring System 2OptiScan Biomedical Receives CE Mark for OptiScanner Automatic Bedside Glucose Monitoring System 3OptiScan Biomedical Receives CE Mark for OptiScanner Automatic Bedside Glucose Monitoring System 4
(Date:5/19/2013)... that can grow using hydrogen gas as its sole ... of carbon. Researchers at the University of Massachusetts, ... of the American Society for Microbiology. , "This represents ... says Amit Kumar, a researcher on the study who, ... Lab Group at the university. , Under the leadership ...
(Date:5/18/2013)... 18, 2013) An increasing number of U.S. ... to resolve, according to research presented at Digestive ... targeting obesity, researchers at the Cleveland Clinic Children,s ... pattern of exhaled breath compared to their lean ... compound levels that can be correlated to potential ...
(Date:5/17/2013)... of proteins in the brain responsible for protecting nerve ... could increase cell survival. , The discovery, made by ... in the EMBO journal with additional comment ... for stroke and other brain diseases. , The research ... a protein, known as SUMO, responsible for controlling the ...
Breaking Biology News(10 mins):New research identifies risks, interventions for children's GI health 2New research identifies risks, interventions for children's GI health 3SUMO wrestling cells reveal new protective mechanism target for stroke 2
... With reducing carbon emissions on the national agenda, a group ... issues on how carbon sinks or carbon sequestration may be ... is the process through which carbon dioxide (CO 2 ) ... through photosynthesis, and stored as carbon in biomass (tree trunks, ...
... radar to GPS, X-ray tomography to Google searches, ... fabric of the modern world. The University of ... Science is hosting its inaugural symposium to spotlight the ... of the news media. Talks will be given ...
... Counting on wetlands restoration projects to protect storm buffeted ... a "losing battle" that provides "false hope" and prevents ... a researcher from Western Carolina University (WCU). ... fall, the media has been filled with the words ...
Cached Biology News:Carbon sinks: Issues, markets, policy 2Wetlands restoration not a panacea for Louisiana coast 2Wetlands restoration not a panacea for Louisiana coast 3
Mouse monoclonal [IA-C6] to MHC Class II I Ab + Ad (FITC) ( Abpromise for all tested applications). Antigen: Tissue / cell preparation of Purified Mouse lymph node B cells...
BD BioCoat Vented Caps for 175 cm2 Flasks...
BD BioCoat Poly-D-Lysine 60 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of poly-D-lysine....
BD Falcon Center-well 60 mm In Vitro Fertilization (IVF) Dish, nonembryotoxic, noncytotoxic, tissue-culture treated polystyrene. (20/sp, 500/ca) Packaging: 20 / sleeve, 500 / case ...
Biology Products: